Insights into the Myeloma XIV/FiTNEss trial: frailty-adjusted therapy in transplant-ineligible NDMM
13 days ago
[{"url":"https://i.ytimg.com/vi/NdKjUl0UClE/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLC7FhQetB_GIa4W6jk-gVoF1zMOQQ","width":360,"height":202},{"url":"https://i.ytimg.com/vi/NdKjUl0UClE/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLC5_GdPQW2NMi7Lt0l372Mwr4k5lw","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/NdKjUl0UClE/mqdefault_6s.webp?du=3000&sqp=CJP0sKkG&rs=AOn4CLBW3_aLooT-bY2e0YNvDZT3FsEDmQ","width":320,"height":180}
[{"text":"Charlotte Pawlyn, BA, MBBChir, MRCP, PhD, FRCPath, The Institute of Cancer Research and The Royal Marsden NHS\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Insights into the Myeloma XIV/FiTNEss trial: frailty-adjusted therapy in transplant-ineligible NDMM by VJHemOnc \u2013 Video Journal of Hematological Oncology 33 views 13 days ago 1 minute, 49 seconds","duration":"1 minute, 49 seconds"}